Market Place
Sourcing Support
Insider trading off Merck-Pandion deal was family affair: SEC
11 Nov 2022 //
FIERCEBIOTECH
Merck Completes Acquisition of Pandion Therapeutics
31 Mar 2021 //
BUSINESSWIRE
Selexis Enters Service Agreement with Pandion Therapeutics to Advance Pandion
16 Mar 2021 //
BUSINESSWIRE
Selexis, Pandion Enter Antibody Service Agreement
16 Mar 2021 //
CONTRACTPHARMA
After three years of courtship (& turndowns), Merck pounced on the first glance
06 Mar 2021 //
ENDPTS
How Pandion went from a $65M Merck offer to a $1.9B done deal
05 Mar 2021 //
FIERCEBIOTECH
Merck to Acquire Pandion Therapeutics
24 Feb 2021 //
BUSINESSWIRE
Pandion Presents Preclinical Data Highlighting Potential -Tethered PD-1
22 Feb 2021 //
GLOBENEWSWIRE
Pandion Therapeutics Announces Positive Top-Line Ph1a Data Showing PT101
04 Jan 2021 //
GLOBENEWSWIRE
Pandion Highlights Potential of Modular Biologics Pipeline for the Treatment
28 Oct 2020 //
GLOBENEWSWIRE
Flagship Pioneering`s 2-becomes-one biotech nabs ex-Pfizer CSO as research lead
21 Sep 2020 //
FIERCE BIOTECH
Pandion Announces Issuance of U.S. Patent for Bifunctional Molecules
09 Jun 2020 //
BUSINESSWIRE
Pandion Therapeutics Announces Close of $80 Million Series B Financing
01 Apr 2020 //
BUSINESSWIRE
Pandion Announces First Subject Dosed in a Phase 1 Clinical Trial of PT101
24 Feb 2020 //
BUSINESSWIRE
Ligand Enters into OmniAb® Platform License Agreement with Pandion Therapeutics
13 Jan 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.